日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Circulating Tumor Cells Predict Response to the DLL3-targeting Bispecific Antibody Tarlatamab.

循环肿瘤细胞可预测对靶向 DLL3 的双特异性抗体 Tarlatamab 的反应。

Mishra Avanish, Meador Catherine B, Kikkeri Kruthika, Cunneely Quinn, Lin Maoxuan, Carmona-LaSalle Thomas J, Huang Shih-Bo, Bell Remy, Putaturo Victor, Xia Weikun, Liang Joyce H, Fang Jacy, San Vicente Sarah, Zielinski Caroline E, Digumarthy Subba R, Hung Yin P, Yeap Beow Y, Edd Jon F, Lawrence Michael S, Sade-Feldman Moshe, Sen Debattama R, Toner Mehmet, Maheswaran Shyamala, Gainor Justin F, Haber Daniel A

Epitope Expression Persists in Circulating Tumor Cells as Breast Cancers Acquire Resistance to Antibody Drug Conjugates

乳腺癌对抗体药物偶联物产生耐药性后,循环肿瘤细胞中仍持续存在表位表达。

Mishra, Avanish; Abelman, Rachel; Cunneely, Quinn; Putaturo, Victor; Deshpande, Akansha A; Bell, Remy; Seider, Elizabeth M; Xu, Katherine H; Shan, Mythreayi; Kelly, Justin; Huang, Shih-Bo; Gopinathan, Kaustav A; Kikkeri, Kruthika; Edd, Jon F; Walsh, John; Dai, Charles S; Ellisen, Leif; Ting, David T; Nieman, Linda; Toner, Mehmet; Bardia, Aditya; Haber, Daniel A; Maheswaran, Shyamala

Targeting S6K/NFκB/SQSTM1/Polθ signaling to suppress radiation resistance in prostate cancer.

靶向 S6K/NFβ/SQSTM1/Polβ 信号通路以抑制前列腺癌的放射抗性

Clark Alison, Villarreal Michelle R, Huang Shih-Bo, Jayamohan Sridharan, Rivas Paul, Hussain Suleman S, Ybarra Meagan, Osmulski Pawel, Gaczynska Maria E, Shim Eun Yong, Smith Tyler, Gupta Yogesh K, Yang Xiaoyu, Delma Caroline R, Natarajan Mohan, Lai Zhao, Wang Li-Ju, Michalek Joel E, Higginson Daniel S, Ikeno Yuji, Ha Chul Soo, Chen Yidong, Ghosh Rita, Kumar Addanki P

SIRT1 inhibition-induced senescence as a strategy to prevent prostate cancer progression

SIRT1抑制诱导衰老作为预防前列腺癌进展的一种策略

Huang, Shih-Bo; Rivas, Paul; Yang, Xiaoyu; Lai, Zhao; Chen, Yidong; Schadler, Keri L; Hu, Ming; Reddick, Robert L; Ghosh, Rita; Kumar, Addanki P